Chicago Atlantic Real Estate Finance Declares Common Stock Dividend of $0.47 for the Second Quarter of 2025 - Chicago Atlantic Real ( NASDAQ:REFI )
CHICAGO, June 16, 2025 ( GLOBE NEWSWIRE ) -- Chicago Atlantic Real Estate Finance, Inc. REFI, a commercial mortgage real estate investment trust, announced that its board of directors has declared a regular quarterly cash dividend of $0.47 per share for the second quarter of 2025.
ORIGENCE ENHANCES ARC OS PLATFORM UNDERWRITING WITH EXPERIAN'S POWERCURVE DECISIONING INTEGRATION
Irvine, California, June 16, 2025 ( GLOBE NEWSWIRE ) -- Origence, a leader in credit union lending technology, announced the integration of Experian's PowerCurve® decisioning suite into the Origence arc OS loan and account origination platform.
USA Rare Earth and Moog Sign Memorandum of Understanding for Delivery of U.S.-Made Neo Magnets for Data Center Cooling Solutions
USAR to Qualify its Magnets for use in Moog's CoreMotion™ Liquid Coolant Distribution Pumps USAR to Qualify its Magnets for use in Moog's CoreMotion™ Liquid Coolant Distribution Pumps ...
RTX's Pratt & Whitney to provide affordable mass propulsion for Leidos' Small Cruise Missile program - RTX ( NYSE:RTX )
PARIS, June 16, 2025 /PRNewswire/ -- Pratt & Whitney, an RTX RTX business, has secured a contract from Dynetics, a Leidos company, to supply TJ150 engines to be integrated with their Small Cruise Missile, known as Black Arrow. The TJ150 is a compact, high performance turbojet engine that can be ...
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635 ( c ) ( 4 )
WATERTOWN, Mass., June 16, 2025 ( GLOBE NEWSWIRE ) -- EyePoint Pharmaceuticals, Inc. ( Nasdaq: EYPT ) , a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory ...
Crescent Biopharma Completes Closing of Merger with GlycoMimetics and Previously Announced Private Placement of $200 Million
Advancing Lead Program, CR-001, a PD-1 x VEGF Bispecific Antibody, and Developing Pipeline of Novel ADCs as Single Agents and in Combination with CR-001 On Track to Submit IND Application for CR-001 in Fourth Quarter of 2025 with Proof-of-Concept Clinical Data Expected in Second Half of 2026
Fury Finalizes Drill Targeting at its Newly Acquired Sakami Gold Project
TORONTO, June 16, 2025 ( GLOBE NEWSWIRE ) -- Fury Gold Mines Limited ( TSX and NYSE American: FURY ) ( "Fury" or the "Company" ) is pleased to announce that is has finalized a number of drill targets at the Sakami gold project located in the Eeyou Istchee Territory in the James Bay region of ...
Nokia announces changes to Group Leadership Team
Nokia Corporation Stock Exchange Release 16 June 2025 at 14:00 EEST Federico Guillén to retire from Nokia on 31 December 2025. He will step down as President of the Network Infrastructure ( NI ) business group and as a member of the Group Leadership Team on 30 June 2025.
BioCryst Presents New Data on the Long-term Efficacy and Safety of ORLADEYO® ( berotralstat ) Across all Ages at EAACI - BioCryst Pharma ( NASDAQ:BCRX )
RESEARCH TRIANGLE PARK, N.C., June 16, 2025 ( GLOBE NEWSWIRE ) -- BioCryst Pharmaceuticals, Inc. BCRX today announced new data on the long-term efficacy and safety of ORLADEYO® ( berotralstat ) for the prophylactic treatment of hereditary angioedema ( HAE ) in patients across all age groups.
iBio Initiates Non-Human Primate Study of First-in-Class Activin E Antibody Following Positive Preclinical Data Demonstrating Prevention in Weight Regain After GLP-1 Treatment - iBio ( NASDAQ:IBIO )
iBio nominates IBIO-610 as development candidate for its first-in-class Activin E antibody New study aims to evaluate the half-life of IBIO-610 in obese, elderly non-human primates ( NHP ) and assess early signs of efficacy on fat reduction and body composition